Taysha Gene Therapies Inc. is carving an indelible mark within the gene therapy landscape, specializing in the treatment of monogenic Central Nervous System (CNS) diseases. Distinguished by its innovative approach, Taysha is driving forward with the development of Adeno-Associated Virus (AAV)-based gene therapies, targeting both rare and common CNS disorders. The company’s trailblazing efforts are […]
Category: Taysha Gene Therapies
Taysha Gene Therapy Advancements for Rett Syndrome
Taysha Gene Therapies, a leading contender in gene therapy innovation, unveiled the latest advancements in its groundbreaking TSHA-102 program at the 2025 International Rett Syndrome Foundation (IRSF) Scientific Meeting. This trailblazing initiative could revolutionize the management of Rett Syndrome, a neurodevelopmental disorder, by enhancing patients’ quality of life and potentially altering disease progression. The TSHA-102 […]
